Immunome, Inc. (IMNM)
18.40
-0.96
(-4.93%)
USD |
NASDAQ |
Nov 10, 09:42
Immunome Cash and Short Term Investments (Quarterly) : 522.70M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 522.70M |
| March 31, 2026 | 582.69M |
| December 31, 2025 | 653.48M |
| September 30, 2025 | 272.64M |
| June 30, 2025 | 268.04M |
| March 31, 2025 | 317.32M |
| December 31, 2024 | 217.30M |
| September 30, 2024 | 240.13M |
| June 30, 2024 | 278.35M |
| March 31, 2024 | 309.71M |
| December 31, 2023 | 138.14M |
| September 30, 2023 | 90.64M |
| Date | Value |
|---|---|
| June 30, 2023 | 38.42M |
| March 31, 2023 | 44.42M |
| December 31, 2022 | 20.32M |
| September 30, 2022 | 27.08M |
| June 30, 2022 | 34.65M |
| March 31, 2022 | 42.88M |
| December 31, 2021 | 49.23M |
| September 30, 2021 | 56.24M |
| June 30, 2021 | 59.83M |
| March 31, 2021 | 36.28M |
| December 31, 2020 | 39.77M |
| September 30, 2020 | 6.744M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Revolution Medicines, Inc. | 3.651B |
| Erasca, Inc. | 268.74M |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |